ArticleEuroasian journal of hepato-gastroenterology

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Yoel A Fleites et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.